News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Year: 2020

DGAP-DD: Epigenomics AG deutsch

Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen 21.10.2020 / 12:41 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 1. Angaben zu den Personen, die Führungsaufgaben wahrnehmen, sowie zu den in enger Beziehung zu ihnen stehenden Personen a) Name Titel: Vorname: […]

Read more

Epigenomics AG hosts conference call on preliminary CMS reimbursement decision

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous19.10.2020 / 08:30 The issuer is solely responsible for the content of this announcement. Epigenomics AG hosts conference call on preliminary CMS reimbursement decision Berlin (Germany) and San Diego, CA (USA), October 19, 2020 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the “Company”) is appalled and vehemently […]

Read more

Epigenomics AG: U.S. Centers for Medicare & Medicaid Services publish negative proposed NCD for Epi proColon

Epigenomics AG / Key word(s): MiscellaneousEpigenomics AG: U.S. Centers for Medicare & Medicaid Services publish negative proposed NCD for Epi proColon 17-Oct-2020 / 00:03 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for […]

Read more

Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Epigenomics AG13.10.2020 / 15:35 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Epigenomics AGGeneststraße 510829 Berlin Deutschland 12th October 2020 Notification pursuant to Sec. 43 of the German Securities Trading Act Dear Sirs, Referring to the voting […]

Read more

Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Epigenomics AG30.09.2020 / 12:13 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Name: Epigenomics AG Street: Geneststraße 5 Postal code: 10829 City: BerlinGermany Legal Entity Identifier (LEI): 549300X1C4U862NDLN97 2. […]

Read more

Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Epigenomics AG25.09.2020 / 17:13 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Epigenomics AGGeneststraße 510829 BerlinDeutschland Notification pursuant to Sec. 43 of the German Securities Trading Act 25th September 2020 Dear Sirs, Referring to the voting rights […]

Read more